BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer
Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Alcura Healthcare Ltd. | - | ~£2,760,000 estimated from lot values | - |
| B. Braun Medical Limited | 02296559 | ~£2,760,000 estimated from lot values | - |
| HealthNet Homecare (UK) Limited | 06856641 | ~£2,760,000 estimated from lot values | - |
| LloydsPharmacy Clinical Homecare | - | ~£2,760,000 estimated from lot values | - |
| Pharmaxo Pharmacy Services Ltd | 06982573 | ~£2,760,000 estimated from lot values | - |
| Sciensus Pharma Services Limited | 02759609 | ~£2,760,000 estimated from lot values | LOBBYIST Crowne Associates Ltd (1 quarter) |
Government spending data: These suppliers have received £752,977,727 in 41,408 payments (over £25k) from NHS Supply Chain (DHSC-funded), Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust, Department of Health and Social Care, The Christie NHS Foundation Trust and 9 more public bodies (2010-04-16 to 2026-03-31).